Jazz Pharmaceuticals plc 4

Director Heather Ann McSharry had 1,855 Jazz Pharmaceuticals ordinary shares disposed of on 2026-08-31 to satisfy tax obligations from RSU vesting.

On August 31, 2026, Jazz Pharmaceuticals plc director Heather Ann McSharry had 1,855 ordinary shares withheld or sold to cover tax obligations arising from the vesting of previously granted restricted stock units, in two Form 4-reported transactions coded as F at prices of approximately $244.64 and $241.39 per share. These tax-related dispositions, which are typically considered routine, reduced her directly held ordinary shares from 20,039 to 18,199 after the first transaction and then to 18,199 after the second, reflecting a non-discretionary sale mechanism tied to equity compensation rather than an open-market decision to sell shares. The aggregate value of the tax-related share dispositions is approximately $447,000 based on the reported transaction prices, leaving her with an estimated remaining equity stake of about $4.4 million in the company at the same price range.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001576068-26-000009

Alert Tier

5